COLLECTIONS
WORKFLOWS
Recent Finacing
Recent Raise
Aquinox Pharmaceuticals develops small-molecule SHIP1 agonist therapeutics for inflammatory diseases and cancer, advancing lead candidate AQX-1125 through clinical trials and continuing SHIP1-focused drug discovery.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors